The majority (96%) of oncogenic Kras driven tumors were graded as adenomas, whereas 50% of Ki tumors had progressed to lung adenocarcinoma 15 weeks after initiation (Fig. 5B). The gene discussed is KRAS; the disease is lung adenocarcinoma.